Focused Ultrasound Shows Promise in Delivering Chemotherapy to Children with Brain Tumors
Table of Contents
A groundbreaking, non-invasive ultrasound technique is offering new hope for children battling brain cancer, representing a significant step forward in the development of targeted drug delivery systems.
Columbia University researchers have, for the first time, demonstrated the safe application of focused ultrasound – a method utilizing sound waves to enhance drug penetration into the brain – in pediatric patients undergoing cancer treatment. The findings, recently published in Science Translational Medicine, detail a study where the technique was used to facilitate chemotherapy delivery in children diagnosed with a particularly aggressive form of brain cancer.
Breaking Through the Blood-Brain Barrier
A major hurdle in treating brain tumors is the blood-brain barrier (BBB), a protective structure that shields the brain but simultaneously prevents many life-saving drugs from reaching cancerous cells. This new approach offers a way to temporarily and controllably open the BBB, allowing chemotherapy to reach the tumor more effectively.
The study focused on three children with diffuse midline glioma (DMG), a rare and devastating brain cancer characterized by a poor prognosis and an average survival rate of less than one year after diagnosis. Researchers combined the ultrasound procedure with chemotherapy administration, successfully opening the blood-brain barrier in all patients. This allowed the drug to reach the tumor, resulting in observed improvements in patient mobility.
A Safe and Comfortable Procedure
While the children involved in the initial study ultimately succumbed to cancer or complications related to Covid-19, researchers emphasize the primary goal was to establish the safety and feasibility of the technique in a real-world clinical setting. “The main objective of the study was to demonstrate the safety and the possibility of applying the technique in the real environment,” one researcher stated.
The procedure stands apart from existing methods, which often require patients to remain stationary within an MRI machine. The Columbia-developed device allows for treatment outside of the MRI environment, utilizing pre-obtained images for precise guidance. The treatment is administered with a hand-held device, creating a less stressful experience for young patients, who can comfortably sit, read, or play during the brief, painless procedure.
How Focused Ultrasound Works
The technology hinges on the use of gaseous microbubbles covered in lipids, introduced into the cerebral vessels. When exposed to ultrasound waves, these microbubbles expand and contract, creating microscopic openings that allow drugs to penetrate the tumor tissue. Laboratory testing has consistently shown that the blood-brain barrier can be safely and temporarily relaxed, enabling therapeutic molecule passage before returning to its normal state.
Future Directions and Ongoing Research
Researchers believe that, with established safety protocols, the technique can be refined for use in earlier stages of the disease, potentially utilizing lower systemic drug doses while maximizing concentration within the brain.
Columbia University has already initiated a follow-up study investigating the combination of focused ultrasound with etoposide, a regulatory-approved drug known for its effectiveness against brain cancer cells. Future results will be critical in determining whether this technology can meaningfully improve survival rates for children with brain tumors – a field where therapeutic advancements have been limited in recent decades.
.
The ability to overcome the blood-brain barrier could fundamentally change the treatment paradigm for brain tumors, offering a beacon of hope for young patients and their families.
